Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 29 05 2020
revised: 10 06 2020
accepted: 15 06 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 25 8 2020
Statut: ppublish

Résumé

The coronavirus disease-2019 (COVID-19) pandemic caused unprecedented demand and burden on emergency health care services in New York City. We aim to describe our experience providing acute stroke care at a comprehensive stroke center (CSC) and the impact of the pandemic on the quality of care for patients presenting with acute ischemic stroke (AIS). We retrospectively analyzed data from a quality improvement registry of consecutive AIS patients at New York University Langone Health's CSC between 06/01/2019-05/15/2020. During the early stages of the pandemic, the acute stroke process was modified to incorporate COVID-19 screening, testing, and other precautionary measures. We compared stroke quality metrics including treatment times and discharge outcomes of AIS patients during the pandemic (03/012020-05/152020) compared with a historical pre-pandemic group (6/1/2019-2/29/2020). A total of 754 patients (pandemic-120; pre-pandemic-634) were admitted with a principal diagnosis of AIS; 198 (26.3%) received alteplase and/or mechanical thrombectomy. Despite longer median door to head CT times (16 vs 12 minutes; p = 0.05) and a trend towards longer door to groin puncture times (79.5 vs. 71 min, p = 0.06), the time to alteplase administration (36 vs 35 min; p = 0.83), door to reperfusion times (103 vs 97 min, p = 0.18) and defect-free care (95.2% vs 94.7%; p = 0.84) were similar in the pandemic and pre-pandemic groups. Successful recanalization rates (TICI≥2b) were also similar (82.6% vs. 86.7%, p = 0.48). After adjusting for stroke severity, age and a prior history of transient ischemic attack/stroke, pandemic patients had increased discharge mortality (adjusted OR 2.90 95% CI 1.77 - 7.17, p = 0.021) CONCLUSION: Despite unprecedented demands on emergency healthcare services, early multidisciplinary efforts to adapt the acute stroke treatment process resulted in keeping the stroke quality time metrics close to pre-pandemic levels. Future studies will be needed with a larger cohort comparing discharge and long-term outcomes between pre-pandemic and pandemic AIS patients.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The coronavirus disease-2019 (COVID-19) pandemic caused unprecedented demand and burden on emergency health care services in New York City. We aim to describe our experience providing acute stroke care at a comprehensive stroke center (CSC) and the impact of the pandemic on the quality of care for patients presenting with acute ischemic stroke (AIS).
METHODS METHODS
We retrospectively analyzed data from a quality improvement registry of consecutive AIS patients at New York University Langone Health's CSC between 06/01/2019-05/15/2020. During the early stages of the pandemic, the acute stroke process was modified to incorporate COVID-19 screening, testing, and other precautionary measures. We compared stroke quality metrics including treatment times and discharge outcomes of AIS patients during the pandemic (03/012020-05/152020) compared with a historical pre-pandemic group (6/1/2019-2/29/2020).
RESULTS RESULTS
A total of 754 patients (pandemic-120; pre-pandemic-634) were admitted with a principal diagnosis of AIS; 198 (26.3%) received alteplase and/or mechanical thrombectomy. Despite longer median door to head CT times (16 vs 12 minutes; p = 0.05) and a trend towards longer door to groin puncture times (79.5 vs. 71 min, p = 0.06), the time to alteplase administration (36 vs 35 min; p = 0.83), door to reperfusion times (103 vs 97 min, p = 0.18) and defect-free care (95.2% vs 94.7%; p = 0.84) were similar in the pandemic and pre-pandemic groups. Successful recanalization rates (TICI≥2b) were also similar (82.6% vs. 86.7%, p = 0.48). After adjusting for stroke severity, age and a prior history of transient ischemic attack/stroke, pandemic patients had increased discharge mortality (adjusted OR 2.90 95% CI 1.77 - 7.17, p = 0.021) CONCLUSION: Despite unprecedented demands on emergency healthcare services, early multidisciplinary efforts to adapt the acute stroke treatment process resulted in keeping the stroke quality time metrics close to pre-pandemic levels. Future studies will be needed with a larger cohort comparing discharge and long-term outcomes between pre-pandemic and pandemic AIS patients.

Identifiants

pubmed: 32807471
pii: S1052-3057(20)30486-9
doi: 10.1016/j.jstrokecerebrovasdis.2020.105068
pmc: PMC7305900
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105068

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Références

Stroke. 2020 Jun;51(6):1896-1901
pubmed: 32347790
Neurology. 2020 Jun 16;94(24):e2608-e2614
pubmed: 32385187
Stroke. 2020 Jul;51(7):2273-2275
pubmed: 32432995
Stroke. 2020 Jul;51(7):2228-2231
pubmed: 32432998
Stroke. 2020 Aug;51(8):2540-2543
pubmed: 32466736
Stroke. 2020 Jul;51(7):2002-2011
pubmed: 32432996
J Stroke Cerebrovasc Dis. 2020 Jul;29(7):104881
pubmed: 32334918
Stroke. 2020 Jul;51(7):1991-1995
pubmed: 32438895
Stroke. 2020 Jul;51(7):1996-2001
pubmed: 32432997
Int J Stroke. 2020 Jun;15(4):385-389
pubmed: 32310015

Auteurs

Shashank Agarwal (S)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: shashank.agarwal@nyumc.org.

Erica Scher (E)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: erica.Scher@nyulangone.org.

Nirmala Rossan-Raghunath (N)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Nirmala.Rossan-Raghunath@nyulangone.org.

Dilshad Marolia (D)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Dilshad.Marolia@nyulangone.org.

Mariya Butnar (M)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Mariya.Butnar@nyulangone.org.

Jose Torres (J)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Jose.Torres2@nyulangone.org.

Cen Zhang (C)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Cen.Zhang@nyulangone.org.

Sun Kim (S)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Sun.Kim@nyulangone.org.

Matthew Sanger (M)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Matt.Sanger@nyulangone.org.

Kelley Humbert (K)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Kelley.Humbert@nyulangone.org.

Omar Tanweer (O)

Department of Neurosurgery, New York Langone Health, New York, NY, United States. Electronic address: Omar.Tanweer@nyulangone.org.

Maksim Shapiro (M)

Department of Radiology, New York Langone Health, New York, NY, United States. Electronic address: Maksim.Shapiro@nyulangone.org.

Eytan Raz (E)

Department of Radiology, New York Langone Health, New York, NY, United States. Electronic address: Eytan.Raz@nyulangone.org.

Erez Nossek (E)

Department of Neurosurgery, New York Langone Health, New York, NY, United States. Electronic address: Erez.Nossek@nyulangone.org.

Peter K Nelson (PK)

Department of Radiology, New York Langone Health, New York, NY, United States. Electronic address: Peter.Nelson@nyulangone.org.

Howard A Riina (HA)

Department of Neurosurgery, New York Langone Health, New York, NY, United States. Electronic address: Howard.Riina@nyulangone.org.

Adam de Havenon (A)

Department of Neurology, University of Utah, Salt Lake City, UT, United States. Electronic address: Adam.DeHavenon@hsc.utah.edu.

Michael Wachs (M)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Michael.Wachs@nyulangone.org.

Jeffrey Farkas (J)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Jeffrey.Farkas@nyulangone.org.

Ambooj Tiwari (A)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Ambooj.Tiwari@nyulangone.org.

Karthikeyan Arcot (K)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Karthikeyan.Arcot@nyulangone.org.

David Turkel Parella (DT)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: David.Turkel-Parrella@nyulangone.org.

Jeremy Liff (J)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Jeremy.Liff@nyulangone.org.

Tina Wu (T)

Department of Emergency Medicine, New York Langone Health, New York, NY, United States. Electronic address: Tina.Wu@nyulangone.org.

Ian Wittman (I)

Department of Emergency Medicine, New York Langone Health, New York, NY, United States. Electronic address: Ian.Wittman@nyulangone.org.

Reed Caldwell (R)

Department of Emergency Medicine, New York Langone Health, New York, NY, United States. Electronic address: Reed.Caldwell@nyulangone.org.

Jennifer Frontera (J)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Jennifer.Frontera@nyulangone.org.

Aaron Lord (A)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Aaron.Lord@nyulangone.org.

Koto Ishida (K)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: Koto.Ishida@nyulangone.org.

Shadi Yaghi (S)

Department of Neurology, New York Langone Health, New York, NY, United States. Electronic address: shadiyaghi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH